Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Construction in Progress (2017 - 2022)

Marimed has reported Construction in Progress over the past 6 years, most recently at $3.6 million for Q1 2022.

  • Quarterly Construction in Progress fell 24.27% to $3.6 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Mar 2022, down 24.27% year-over-year, with the annual reading at $10.6 million for FY2021, 236.49% up from the prior year.
  • Construction in Progress was $3.6 million for Q1 2022 at Marimed, down from $10.6 million in the prior quarter.
  • Over five years, Construction in Progress peaked at $12.2 million in Q4 2018 and troughed at $1.1 million in Q1 2019.
  • The 5-year median for Construction in Progress is $3.6 million (2022), against an average of $5.5 million.
  • Year-over-year, Construction in Progress tumbled 77.05% in 2019 and then soared 236.49% in 2021.
  • A 5-year view of Construction in Progress shows it stood at $12.2 million in 2018, then tumbled by 77.05% to $2.8 million in 2019, then rose by 12.18% to $3.1 million in 2020, then soared by 236.49% to $10.6 million in 2021, then plummeted by 65.61% to $3.6 million in 2022.
  • Per Business Quant, the three most recent readings for MRMD's Construction in Progress are $3.6 million (Q1 2022), $10.6 million (Q4 2021), and $8.9 million (Q3 2021).